Background: Feline nasal lymphoma (NLSA) is a condition for which no standard of care exists. Hypothesis: There is no difference in survival times of cats with NLSA treated with single or multimodality therapy. Animals: Records from 97 cats diagnosed with NLSA were examined. Methods: The purpose of this retrospective study was to compare the survival times of cats with NLSA treated with radiation therapy (RT) alone, chemotherapy alone, or RT 1 chemotherapy and identify potential prognostic variables that affected survival. Cats were grouped according to therapy: RT 1 chemotherapy (n 5 60), RT alone (n 5 19), or chemotherapy alone (n 5 18).Results: Survival was calculated with 2 methods. The 1st survival analysis (method A) included all cats, but counted only deaths caused by progressive NLSA. The median survival time (MST), regardless of therapy modality, was 536 days. The 2nd survival analysis (method B) also included all cats and counted all deaths, regardless of cause, as events. The overall MST calculated for all deaths was 172 days. A negative independent prognostic variable identified was anemia (P o .001), and positive independent prognostic variables were a complete response to therapy (P o .001) and total radiation dose 432 Gy (P 5 .03).Conclusions and Clinical Importance: There were no significant differences in survival times among the 3 treatment groups but these results suggest that the addition of higher doses of RT to a cat's treatment protocol may control local disease and therefore influence survival.

Results suggested that 131I therapy may result in prolonged survival times in dogs with nonresectable thyroid tumors, regardless of serum thyroxine concentration prior to treatment. Dogs undergoing 131I therapy should be monitored for signs of bone marrow suppression.

A description of the clinical behavior, radiographic signs, histologic appearance, therapy, and clinical sequelae in 15 cats with primary bone tumors seen over a 10‐year period is presented. Seven tumor types were identified: osteosarcoma (3 cats), chondrosarcoma (4 cats), parosteal osteosarcoma (2 cats), giant cell tumor (1 cat), ossifying fibroma (1 cat), solitary osteochondroma (1 cat), and osteochondromatosis (3 cats). The cats had a mean age of 8.4 years and there was no sex predilection. Domestic short‐hair, mixed‐breed cats comprised 80% of affected cats. A retrospective review of feline osteosarcomas was made and data was compared to that of canine osteosarcomas. Significant differences were the incidence of metastatic disease, the age on onset, forelimb‐hindlimb incidence, and duration of clinical signs. Five tumors were surgically excised successfully. Radiotherapy controlled one unresectable tumor. Three young adult cats had osteochondromatosis with progressively enlarging lesions limited to flat and irregular bones. Two of the three cats were FeLV positive. Metastatic disease was not detected in any cats in this study.

Skeletal radiographs of four dogs with confirmed visceral leishmaniasis were reviewed. The dogs had lived in the Mediterranean area for six to 36 months prior to returning to the United States, where they lived for an additional six to 41 months before clinical signs appeared. Clinical findings included lameness, fever, cutaneous lesions, muscle atrophy, lymphadenopathy, hepatosplenomegaly, and weight loss. The dogs exhibited two distinct radiographic patterns. Periosteal proliferation and increased intramedullary radiopacity of long and flat bones occurred in two dogs. Osteolysis of bones of the carpus, tarsus, and stifle was noted in two dogs. Differences in radiographic appearance were presumed to be due to different hematogenous routes of infection. Leishmaniasis should be considered in the differential diagnosis of dogs that have traveled in endemic areas and exhibit the described radiographic changes.